IL6 can also induce pro-angiogenic effects, inducing VEGF expression in tumour-associated endothelial cells through STAT3 and MAPK [110], while the IL6 inflammatory loop can activate mechanisms linked to drug resistance [111,112,113]. This evidence concerns the gene IL6 and neoplasm.